Nalidixic acid having a naphthyridine ring has been known to show excellent antibacterial activity, especially against gram-negative bacteria. As a part of the investigations on new antibacterial agents, a series of 1,8-naphthyridine derivatives have been prepared.3) On the basis of antibacterial activity in vitro and in vivo, potassium 1,4-dihydro-1-methy1-7-[2-(5-nitro-2-furyl)vinyl]-4-oxo-1,8-naphthyridine-3-carboxylate (677K) was found as the most promising compound as a novel antibacterial agent in this series. Structure-activity relationships are also discussed. Material4) and Method I. In Vitro Studies-a) Antibacterial Tests: The antibacterial activities were determined against various gram-positive and gram-negative bacteria by the standard serial dilution method in the semi-synthetic medium of Gakken and Mueller-Hinton agar medium containing 1% glucose. Test compounds were dissolved in ethylene glycol and added to the medium. Table I shows the microorganisms and media used 1) This work was presented at the 88th Annual Meeting of the Pharmaceutical Society of Japan, April 1968. 2) Location:
Minamifunabori-cho, Edogawa-ku, Tokyo. 3) a) S. Nishigaki, F. Yoneda, K. Ogiwara, T. Naito, R. Dohmori, S. Kadoya, Y. Tanaka, and I. Takamura Aqueous suspension of the compound was administered orally to mice a few hours (2-4hr) after infection of streptococci or diplococci. In staphlococcal infection, oral medication was made once daily for ten consecutive days, and once daily for five consecutive days in salmonella infection.
Effect of test compounds in experimental infection of streptococci, diplococci, or salmonella was evaluated by survival rate of mice . In staphylococcal infection, the effect was evaluated not only by the survival rate of mice, but also the 
Result
I. In Vitro Studies 1) Antibacterial Activity of Naphthyridine Derivatives-The in vitro activities of 64 compounds against laboratory strains of bacteria are shown in Table II . Naphthyridine 3-carboxylic acid derivatives were more active than the corresponding esters or amides. Further, the compounds substituted with lower alkyl (methyl, ethyl, propyl) or aminoalkyl group at 1-position of naphthyridine ring were more active than other compounds. (Table  III) . (Table  III) .
3) Comparison of Antibacterial Activities of 677 and 837-From the results described above, 677 and 837 were selected from the seven compounds according to the MIC, and the antibacterial activities of 677 and 837 were compared with those of DF and NA, both in vitro and in vivo. Potassium salts of 677 and 837 (677K and 837K) were used for further experiments because they were more soluble in water than the corresponding free acids.
i) Activities against Common Pathogenic Bacteria, Tubercle Bacilli, and Fungi: The activities of 677K and 837K against 18 strains of gram-negative bacteria were compared with iii) Antibacterial Activities against Multiple Drug Resistant Strains: The antibacterial activity of 677K and 837K against multiple drug resistant strains isolated from clinical specimen was tested by agar streak method on heart infusion medium. The inoculum, given was 103 times as large in size as that used in the MIC test. Although the organisms were resistant to CP, SM, TC, AB-PC and KM as shown in Table VIII , 677K and 837K showed high activities against these organisms, and 677K was superior to 837K in activity.
II. In Vivo Studies 1) Effect against Experimental Streptococcal Infection in Mice-The chemotherapeutic effect of 677K, 837K, and DF against experimental streptococcal infection in mice is shown in Fig. 1 . The mice treated with 677K or 837K showed a higher survival rate than those treated with DF during 7 days of experiment, while all the control mice died within 2 days. ED50 values were calculated from the survival rate on the 4th day after infection according 2) Effect against Experimental Pneumococcal Infection in Mice-As shown in Fig. 2 , the survival rate of mice medicated with 677K on the 7th day after infection was 100%, and was higher than that of 837K (70%) and DF (30%), while all the control mice died within 4 days after infection. ED50 values of 677K on the 4th day after infection was less than 12.5 mg/kg, and those of 837K and DF were 31.9 and more than 100 mg/kg, respectively. 3) Effect against Experimental Staphylococcal Infection in Mice-The effect of 677K, 837K, and DF in doses of 25, 50, or 100 mg/kg against experimental staphylococcal infection in mice was evaluated by the survival rate of mice, the grade of abscess formed, and viable count of bacteria in the kidneys. Fig. 3 shows the degree of abscess formation and the viable count of bacteria in the kidneys. Judging from the remarkable multiplication of bacteria in dead mice, septicemia might be the cause of death in these mice. It was assumed that bacterial count of dead mice was more numerous than that of survived mice. As maximum bacterial count of a survived mice was 109 cells per homogenated 1ml, accordingly, the bacterial count was assumed to be more than 109 in every dead mouse.
As a result, 677K was proved to be the best in all respects, and 837K and DF were arranged in the order of decreasing potency.
In these respects the effectiveness of these three compounds was agreement with that evaluated ED50 ranking.
4) Effect against Experimental Typhosis in
Mice-Several experiments have been carried out to determine the chemotherapeutic effect of the test compounds against experimental typhoid infection in mice. In these experiments three or four different doses have been administered. Fig. 4 illustrates the survival rate which was obtained in mice treated with a dose of 200 mg/kg. In this experiment, Sal. enteritidis 11 was injected intraperitoneally and medications were carried out orally once daily for five days. The medication started about 2 hr after injection. The effects were determined by the survival rate of mice. As shown in Fig. 4 , all of the control mice died within 8 days. The mice medicated with 677K or 837K were survived on the 7th day after infection at the rate of 10% and 70%, respectively. ED50 values calculated by the method of Reed-Muench were more than 200 mg/kg for 677K and 129 mg/kg for 837K. Compound 837K was better than 677K in this experiment, contrary to the results obtained from infection experiments with gram-positive bacteria. Fig. 5 . In view of such effects of these drugs after 7 days of infection, the test compounds might be divided into two groups, a higher active group of 677K and AB-PC, and a lower active group of TC, DF, CP, and SIZ. Compound 677K was more active than the others. Compound 717 and 788 lacking nitro group were almost inactive against most species of bacteria except Staph. aureus and Ery. rhusiopathiae, and compound 1041 was inactive against all species of bacteria used. This indicates that a nitro group is necessary for antibacterial effectiveness, as reported by many workers.7) Further, the antibacterial activities of 3-carboxynaphthyridine were higher than those of esterified or amidated compounds.
In connection with this respect, Lesher8) reported that esterified or amidated NA was active as NA in vivo, although the former was less active than the latter in vitro. He suggested that esterified or amidated NA might be hydrolysed in vivo. Similar phenomenon was reported by Kaminsky9) in the case of oxolinic acid. Accordingly, esterified or amidated 3-carboxynaphthyridine derivative might be active in vivo as the corresponding The results showed that 677K was more active than 837K.
Despite the high effectiveness against all the bacteria used in vitro, 677K
was active against only gram-positive bacteria in vivo. Further, the studies of blood, organ, and urinary levels of 677K are in progress in order to clarify the reason for its ineffectiveness against experimental typhoid infection.
